HONG KONG, May 31, 2021 — A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development and treatment processes in real-time. By…
Revolutionary X-ray Technology From Australia to Transform American Airport Security
SeaTac chosen for Micro-X Inc’s USA headquartersOfficial Opening at 10 am PDT, Friday May 28855 S 192nd Street, Suite B600, Seattle, WA 98148 With: Congressman Adam Smith, chair of the House Armed Services Committee Brigadier Hugh Meggitt representing Australian Defence Staff, Embassy of Australia Stephen Patterson,…
Neteera makes annual CNBC Disruptor 50 list second year running
JERUSALEM, May 27, 2021 — Neteera, global leader in contactless vital signs sensing, has been named for the second year running to the CNBC Disruptor 50, an annual list of private venture-backed companies transforming the economy and the way we live. Over 1,500 nominees contended for the prestigious award this…
PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics
PEYNIER, France, May 12, 2021 — An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020. This disruptive system will revolutionize the radiopharmaceutical production, access and distribution. iMiGiNE will allow clinical…
DiA Imaging Analysis Partners with SonoScape Medical Corporation to Deliver Cardiac Ultrasound AI solutions
BE’ER SHEVA, Israel, and SHENZHEN, China , May 11, 2021 — DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation (300633.SZ), a leading developer and manufacturer of ultrasound systems. As part of the partnership, SonoScape’s…
FDA Grants Donisi De Novo Clearance for Innovative Contact-Free Multiparameter Health Sensing Solution
TEL AVIV, Israel, May 5, 2021 — The U.S. Food and Drug Administration (FDA) has granted Donisi’s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market. Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing…
Cleveland Clinic, Lifebanc and Transplant Connect Develop Automated Donor Referral Process
New system streamlines organ donation process, helping to save, heal more lives through donation, transplantation CLEVELAND, May 4, 2021 — Cleveland Clinic, Lifebanc and Transplant Connect have designed and launched a fully automated donor referral system to streamline the process for hospital staff identifying and evaluating potential organ, tissue and eye…
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute
BASEL, Switzerland, April 28, 2021 — Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On@Pro tool,…
Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression
TOKYO, April 23, 2021 — Jolly Good Inc. ("Jolly Good") and Teijin Pharma Ltd. ("Teijin Pharma") have signed a business partnership agreement to develop VR digital therapeutics ("VR DTx") for Major Depressive Disorder (MDD). Together, they will promote the development of VR DTx for depression, aiming for PMDA regulatory approval. …
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
Alliance pairs world-class treatment hardware and supporting software for superior proton therapy ecosystem STOCKHOLM, March 5, 2021 — Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy, Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration. Monaco brings robust functionality for…